As concerns continue that the US does not have enough diagnostic tests to fully grasp the spread and impact of the coronavirus crisis, the largest medical device lobby group says based on conversations with manufacturers they hope to ramp up production of live-virus total tests to 25 million by April 30.
During a call with reporters on 22 April, AdvaMed CEO Scott Whitaker said the industry is planning on substantially increasing...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?